Wisconsin Senate Bill SB962

Wisconsin 2023-2024 Regular Session

• Introduced: 1/26/24
• Refer: 1/26/24
• Report Pass: 2/13/24
• Engrossed: 2/20/24
• Refer: 3/14/24
• Failed: 4/15/24

Caption

The procedure for adding federal newborn screening recommendations to the state-required newborn screenings, granting rule-making authority, and providing an exemption from emergency rule procedures. (FE)

Impact

The legislation not only modernizes state newborn screening practices but also establishes a consistent framework for the ongoing evaluation of new medical information regarding congenital and metabolic disorders. It allows the DHS to expedite rule-making for newly added disorders, with an obligation to commence testing within six months of rule publication. This approach is designed to enhance public health outcomes by ensuring that newborns are tested for conditions that may not have been previously screened in the state.

Summary

Senate Bill 962 aims to streamline the process for incorporating new federal recommendations for newborn screenings into state laws. It mandates that the Wisconsin Department of Health Services (DHS) evaluate any disorder added to the federal Recommended Uniform Screening Panel (RUSP) after January 1, 2024. The evaluations will help determine whether those disorders should be included in the state's mandatory newborn testing. This bill emphasizes adherence to updated federal guidelines, ensuring that the state's screening processes remain aligned with national standards.

Contention

One potential point of contention surrounding SB962 lies in the flexibility it offers the DHS through the emergency rule-making process. While this could allow for rapid adjustments to screening protocols based on emerging health data, critics may argue that it bypasses public scrutiny typically associated with standard rule-making procedures. Furthermore, the requirement for annual reviews and reevaluations may strain resources in the health department, as it balances existing screening commitments with new evaluations.